In patients with obesity (mean age 51.3 years, 65.6% women), semaglutide compared with non-GLP-1RA anti-obesity medications was associated with lower risk for incident CUD in patients with no prior history CUD (HR: 0.56, 95% CI: 0.420.75), and recurrent CUD diagnosis in patients with a prior history CUD (HR: 0.62, 95% CI: 0.460.84)
CrossRef Improving Lipid Profiles Through Lactobacillus rhamnosus Supplementation in Dyslipidemic Animal Models: A Systematic Review and Meta-Analysis Sungmin Chung, Jiill Jeong, Yeonwoo Park, Bogyeong Lee, Sumin Kang, Gwang-woong Go Foods.2026
What are common side effects of Semaglutide
The medications in this class copy that hormone to lower appetite and help you feel full sooner
follow the products discard instructions or contact the dispensing pharmacy